Calcium channel blockers may increase the risk of glaucomaCalcium channel blockers may be an important modifiable risk factor for glaucoma, possibly through a mechanism that is not related to intraocular pressure. New agent lowers Lp(a) levelsWhile the Canadian Cardiovascular Society’s lipid guidelines recommend a once in a lifetime testing of Lp(a), there are no approved agents for lowering Lp(a) levels. Case report: The eyes have it A recent case at Dr. Robert Dickson's clinic reinforces the importance of asking for more details. Teva to pay US$225M to settle cholesterol drug price fixing charges Another generic drug maker, Glenmark Pharmaceuticals, agreed to pay a US$30 million criminal penalty and to divest its pravastatin business as well. COVID-19 took a toll on heart health and doctors are still grappling with how to help Firefighter and paramedic Mike Camilleri once had no trouble hauling heavy gear up ladders. Now battling long COVID, he gingerly steps onto a treadmill to learn how his heart handles a simple walk. American Heart Association ranks popular diets when it comes to heart health Paleo and ketogenic diets don’t rank as heart-healthy. Low-level drinking comes with risks But risks increase in a dose-response manner. Covering essential medicines saves on overall healthcare costs: study When free medications were given to people who couldn’t afford them, the overall healthcare system saved an average of $1,488 a year per patient. Skip the clopidogrel-ASA? Ticagrelor-ASA may be better for obese stroke patients New study involving 6,412 patients in China looked at how body mass index may affect the response to platelet P2Y receptor inhibitors. U.S. community pharmacies recognized for contributions to public health during pandemic However, some still firmly oppose any effort to increase pharmacists’ scope of practice, including those related to public health activities. First Previous 10 11 12 13 14 Next Last